About Jia Sheng Loo
Form D filings for Lengo Therapeutics in 2023 list Jia Sheng Loo as CEO and director.
Jia Sheng Loo first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jia Sheng Loo in the role, so the role may have started earlier or lasted longer.